Congenital Adrenal Hyperplasia research hub

An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894

This study looks at the long-term safety and effectiveness of a new medicine, atumelnant, for people with Congenital Adrenal Hyperplasia (CAH). It's for those who have already tried atumelnant in a previous study and could benefit from continuing it.

A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

This study is testing a new medicine, atumelnant, for adults with a condition called congenital adrenal hyperplasia (CAH). It aims to see if the medicine is safe, works well, and how the body handles it.

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

This study is looking into a new medication called atumelnant for children and teenagers with a condition called Congenital Adrenal Hyperplasia (CAH). It wants to see if the medication is safe, works well, and how the body handles it.

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SPR001 (Tildacerfont) in Reducing Supraphysiologic Glucocorticoid Use in Adult Subjects with Classic Congenital Adrenal Hyperplasia

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPR001 (Tildacerfont) in Adult Subjects with Classic Congenital Adrenal Hyperplasia